AllisonJuneKaedingMD

Pediatric Hematologic Oncology

Acting Instructor, Pediatric Blood & Marrow Transplantation, University of Washington/Seattle Cancer Care Alliance

Dr. Kaeding is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

4 citations
Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies
Anilkumar Gopalakrishnapillai, Colin Correnti, Kristina Pilat, Ida Lin, Man Kid Chan
Cancers. 2021-11-26
19 citations
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia.
Allison Kaeding, Sonali P. Barwe, Anilkumar Gopalakrishnapillai, Rhonda E. Ries, Todd A. Alonzo
Blood Advances. 2021-05-11
114 citations
The natural history of soy allergy
Jessica H. Savage, Allison J. Kaeding, Elizabeth C. Matsui, Robert A. Wood
The Journal of Allergy and Clinical Immunology. 2009-02-01

Abstracts/Posters

In Vivo Evaluation of Mesothelin As a Therapeutic Target in Pediatric Acute Myeloid Leukemia
Allison Kaeding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Mesothelin Targeting Bites for Pediatric AML: In Vivo Efficacy and Specificity
Allison Kaeding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic Strategies
Allison Kaeding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018